Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and GIP , could offer a promising development for weight treatment. Preliminary human tests have demonstrated https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026